FB2026_02 , released June 18, 2026
Human Disease Model Report: intellectual disability, autosomal dominant 21
Open Close
General Information
Name
intellectual disability, autosomal dominant 21
FlyBase ID
FBhh0001173
Overview

This report describes intellectual disability, autosomal dominant 21, which shows dominant inheritance. The human gene implicated in this disease is CTCF, a versatile insulator and transcriptional regulator. There is a single high-ranking ortholog of CTCF in Drosophila, CTCF. Several alleles have been generated for CTCF, including hypomorphic alleles, RNAi targeting constructs, and alleles generated by insertional mutagenesis.

The human gene CTCF has not been introduced into flies.

Although overexpression or reduction of CTCF does not change neuromuscular junction anatomy greatly, both manipulations of CTCF levels impairs the flies' climbing ability, especially when CTCF is overexpressed in glia or motorneurons. A hypomorphic mutant of CTCF has impaired memory (both short- and long-term) and learning, as shown in a courtship conditioning assay.

[updated Jan 2020 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: intellectual disability, autosomal dominant
Symptoms and phenotype

Intellectual disability is characterized by impairments in intellectual functioning and adaptive behavior; symptoms must be present before a child becomes 18 years old (http://medical-dictionary.thefreedictionary.com/mental+retardation; 2016.01.19).

Intellectual disability can be subdivided into syndromic forms, characterized by cognitive impairment accompanied by dysmorphic features, malformations or neurological abnormalities, and nonsyndromic forms, characterized by cognitive impairment without additional features (Basel-Vanagaite, 2008; DOI: 10.1002/9780470015902.a0021454).

Specific Disease Summary: intellectual disability, autosomal dominant 21
OMIM report

[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21; MRD21](https://omim.org/entry/615502)

Human gene(s) implicated

[CCCTC-BINDING FACTOR; CTCF](https://omim.org/entry/604167)

Symptoms and phenotype

All but one (due to young age) of the 36 affected individuals with intragenic CTCF aberrations classified as pathogenic or likely pathogenic presented with developmental delay and/or ID. The clinical spectrum of other phenotypes (cognitive impairment, walking age, age of first words, microcephaly, behavioral anomalies, cardiac defects, cleft palate, hearing or vision impairment) was highly variable. (Adapted from Konrad et al. 2019, FBrf0244177.)

Individuals with mutations in CTCF have symptoms including intellectual disability and microcephaly. [from MIM:615502, 2020.01.22]

Genetics

Mental retardation-21 (MRD21) is caused by heterozygous mutation in the CTCF gene (604167) on chromosome 16q22. [from MIM:615502, 2020.01.22]

The identified aberrations in CTCF include two large deletions in 16q22.1, encompassing CTCF plus 26 or 43 neighboring genes, respectively. In addition, the following variants were identified: six frameshifting variants (including a deletion of exon 8); two nonsense variants; two variants in the splice acceptor site of exon 4, for one of which in-frame deletion of exon 4 was demonstrated; and 20 different missense variants. (Adapted from Konrad et al. 2019, FBrf0244177.)

Cellular phenotype and pathology
Molecular information

CCCTC-binding factor (CTCF) is an important chromatin organizer involved in a range of gene regulation processes. When bound to insulator elements, CTCF can prevent spreading of inactive heterochromatin into neighboring regions and shield particular gene promoters from enhancer function. This enhancer blocking by CTCF might be methylation sensitive. CTCF is involved in maintaining three-dimensional chromatin structure, imprinting, X inactivation, and nucleosome positioning. (From Gregor et al. 2013 and references therein, pubmed:23746550.)

Transcriptional insulators are DNA elements that set boundaries on the actions of enhancer and silencer elements and thereby organize the eukaryotic genome into regulatory domains (Kuhn and Geyer, 2003, pubmed:12787766). All vertebrate insulators appear to use the versatile CTCF protein. CTCF uses various combinations of its 11 zinc fingers to recognize a variety of unrelated DNA sequences. Once bound to DNA, CTCF can function as a transcriptional insulator, repressor, or activator, depending on the context of the binding site (Jeong and Pfeifer, 2004, pubmed:15454938). [from MIM:604167, 2020.01.22]

External links
Disease synonyms
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    One to one: 1 human gene to 1 Drosophila gene.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Gene Snapshot
      CTCF (CTCF) encodes a ubiquitous transcription factor that binds to insulators and domain boundaries. It mediates insulator function and blocks enhancers by binding to the product of Cp190. It contributes to long-range chromatin interaction, organizes chromatin domain boundaries and coordinates nuclear architecture. [Date last reviewed: 2019-03-07]
      Cellular component (GO)
      Gene Groups / Pathways
      Comments on ortholog(s)

      Single, high-ranking ortholog of human CTCF.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (30 groups)
        protein-protein
        Interacting group
        Assay
        References
        anti tag coimmunoprecipitation, anti tag western blot, molecular sieving, molecular weight estimation by staining, two hybrid, cross-linking study, light scattering, two hybrid array, protein cross-linking with a bifunctional reagent, bimolecular fluorescence complementation, fluorescence microscopy
        bimolecular fluorescence complementation, fluorescence microscopy
        anti tag coimmunoprecipitation, peptide massfingerprinting
        affinity chromatography technology, western blot
        anti tag coimmunoprecipitation, anti bait coimmunoprecipitation, western blot
        pull down, Identification by mass spectrometry
        anti tag coimmunoprecipitation, anti bait coimmunoprecipitation, western blot
        anti tag coimmunoprecipitation, western blot
        anti bait coimmunoprecipitation, western blot, pull down, Identification by mass spectrometry, anti tag coimmunoprecipitation, molecular weight estimation by staining, two hybrid, anti tag western blot, peptide massfingerprinting
        anti bait coimmunoprecipitation, western blot, pull down, molecular weight estimation by staining, two hybrid
        anti bait coimmunoprecipitation, western blot
        anti tag coimmunoprecipitation, peptide massfingerprinting
        pull down, Identification by mass spectrometry
        pull down, Identification by mass spectrometry
        anti tag coimmunoprecipitation, anti bait coimmunoprecipitation, western blot
        pull down, molecular weight estimation by staining, Identification by mass spectrometry
        anti tag coimmunoprecipitation, anti bait coimmunoprecipitation, western blot
        anti tag coimmunoprecipitation, anti bait coimmunoprecipitation, western blot
        anti bait coimmunoprecipitation, western blot
        anti tag coimmunoprecipitation, anti bait coimmunoprecipitation, western blot
        anti bait coimmunoprecipitation, western blot
        anti bait coimmunoprecipitation, western blot
        anti tag coimmunoprecipitation, anti bait coimmunoprecipitation, western blot
        pull down, molecular weight estimation by staining, Identification by mass spectrometry
        pull down, molecular weight estimation by staining
        pull down, Identification by mass spectrometry
        pull down, Identification by mass spectrometry
        bimolecular fluorescence complementation, fluorescence microscopy
        pull down, Identification by mass spectrometry, molecular weight estimation by staining
        Alleles Reported to Model Human Disease (Disease Ontology) (2 alleles)
        Models Based on Experimental Evidence ( 2 )
        Modifiers Based on Experimental Evidence ( 0 )
        Allele
        Disease
        Interaction
        References
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        amorphic allele - molecular evidence
        CRISPR/Cas9
        amorphic allele - molecular evidence
        CRISPR/Cas9
        References (4)